19-Hydroxyandrostenedione - A Factor in Pregnancy Hypertension
- 1 January 1985
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Hypertension. Part B: Hypertension in Pregnancy
- Vol. 4 (2-3) , 127-139
- https://doi.org/10.3109/10641958509020965
Abstract
39 normotensive pregnant women (52 samples) and 47 patients with hypertensive disease of pregnancy (69 samples) between gestation 26 and 41 weeks were examined. The average plasma concentration of 19-hydroxyandrostenedione (19-OH-A) in the hypertensive pregnant women was significantly higher (p<t).001, mean ± standard deviation 482 ± 96.3 pg/ml) than that of the normotensive pregnant women (345 ± 60.2 pg/ml). 19-OH-A concentration was Independent of length of gestation in both normotensive or hypertensive pregnant women.Keywords
This publication has 7 references indexed in Scilit:
- Fetal sex and pre‐eclampsia in primigravidaeBJOG: An International Journal of Obstetrics and Gynaecology, 1983
- Evidence that 19-hydroxyandrostenedione is secreted by the adrenal cortex and is under the control of ACTH and the renin-angiotensin system in manBiochemical and Biophysical Research Communications, 1982
- 19-Hydroxyandrostenedione as a new hypertensinogenic agentThe Journal of Steroid Biochemistry and Molecular Biology, 1982
- Desoxycorticosterone in normal pregnancyAmerican Journal of Obstetrics and Gynecology, 1978
- Metabolism of 19-Hydroxyandrostenedione in Human Subjects Urinary Excretion of Conjugates*Journal of Clinical Endocrinology & Metabolism, 1978
- BIOSYNTHESIS OF OESTROGENS AND THEIR INTER-CONVERSION IN HUMAN PLACENTAE FROM NORMAL AND TOXAEMIC PREGNANCIESClinical Endocrinology, 1975
- Role of 19-Hydroxy,Δ4-Androstene-3,17-Dione as an Intermediate for Aromatization of Δ4-Androstene-3,17-Dione by Placental Microsomes1Endocrinology, 1962